Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monogram Health is a leading value-based specialty provider of in-home clinical care and benefit management services for patients living with polychronic conditions, specifically chronic kidney disease (CKD) and end-stage renal disease (ESRD). Founded in 2019 and headquartered in Nashville, the company utilizes proprietary artificial intelligence and predictive analytics to identify high-risk patients and deliver personalized, evidence-based interventions directly in the home. Their multidisciplinary care teams include nephrologists, cardiologists, endocrinologists, and social workers who coordinate treatment to delay disease progression and reduce hospitalizations. Monogram Health operates across more than 30 states, partnering with major health plans to transform the delivery of complex chronic care through a high-touch, patient-centric model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monogram Integrated Health Services.